Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

Fractyl Health (GUTS) presented the poster, “Duodenal Mucosal Resurfacing Durably Maintains Weight Loss in Metabolic Disease,” on ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, today announced topline int ...

Kaylene Big Knife grew up playing in the hills of the Rocky Boy’s Indian Reservation in north central Montana. She remembers ...

Q3 2024 Earnings Call Transcript November 7, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.04, ...

Q3 2024 Earnings Call Transcript November 7, 2024 4:30 AM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period ended ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and ...

The Native American College will welcome its first cohort in Fall 2025 and integrate tribal values, traditions and community ...

Marlee Huskey wanted to deepen her studies in public health and learn more about her Native American culture. The Michigan ...